ORION Corp. (KRX:271560)
South Korea · Delayed Price · Currency is KRW 130,000
0.00 (0.00%)
Last updated: Apr 8, 2026, 2:06 PM KST
ORION Revenue
In the year 2025, ORION had annual revenue of 3.33T KRW with 7.35% growth. ORION had revenue of 924.58B in the quarter ending December 31, 2025, with 7.28% growth.
Revenue
3.33T
Revenue Growth
+7.35%
P/S Ratio
1.54
Revenue / Employee
2.27B
Employees
1,471
Market Cap
5.14T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.33T | 228.10B | 7.35% |
| Dec 31, 2024 | 3.10T | 191.98B | 6.59% |
| Dec 31, 2023 | 2.91T | 39.11B | 1.36% |
| Dec 31, 2022 | 2.87T | 517.75B | 21.98% |
| Dec 31, 2021 | 2.36T | 125.68B | 5.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| E-MART | 28.97T |
| CJ Cheiljedang | 27.34T |
| BGF Retail | 9.06T |
| KT&G Corporation | 6.58T |
| LG H&H | 6.36T |
| AMOREPACIFIC Holdings | 4.62T |
| Amorepacific | 4.25T |
| Cosmax | 2.40T |
ORION News
- 9 months ago - Orion Corporation's financial reporting and Annual General Meeting in 2026 - Benzinga
- 11 months ago - Shilpa Medicare subsidiary partners with Orion Corporation to commercialize Recombinant Human Albumin in Europe - Business Upturn